Editorial: in vitro and in vivo non-clinical models of kidney cancers

• Valérian Dormoy,
• Odile Filhol,
• Carole Sourbier,
• Thierry Massfelder

Affiliations

Valérian Dormoy

INSERM (French National Institute of Health and Medical Research) UMR-S1250, P3Cell, Université de Reims Champagne Ardenne, SFR CAP-SANTE, Reims, France

Odile Filhol

INSERM (French National Institute of Health and Medical Research) UMR 1292-Interdisciplinary Research Institute of Grenoble (IRIG)-Biosanté, University Grenoble Alpes, CEA, Grenoble, France

Carole Sourbier

Division of Biotechnology Review and Research 1, Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, United States Food and Drug Administration, Silver Spring, MD, United States

Thierry Massfelder

INSERM (French National Institute of Health and Medical Research) UMR_S1260, Université de Strasbourg, Regenerative Nanomedicine, Centre de Recherche en Biomédecine de Strasbourg, Strasbourg, France